iBio extends $1.5M promissory note maturity with Safi Biotherapeutics to June 19, 2026

iBio, Inc.

Note originally issued June 19, 2023 in principal amount of $1,500,000.
Maturity extended from June 19, 2025 to June 19, 2026 by mutual consent.
All accrued interest must be paid at the time of the extension.
Extension agreement dated June 17, 2025.

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.